Natco Pharma Limited

Industry

  • Pharmaceuticals
    • Generic Drugs
    • Vaccines

Other Names/Subsidiaries

  • Dash Pharmaceutical
See more in Biomedtracker

Latest on Natco Pharma Limited

Generics Bulletin

Gateway To Africa: Natco Bids For 35.75% Of Adcock Ingram

 
• By Anju Ghangurde

Natco Pharma plans to acquire over 35% in Adcock Ingram as it seeks to open up new opportunities in South Africa for both portfolio and market expansion. The Hyderabad, India-based company expects to

Scrip

Gateway To Africa: Natco Bids For 35.75% Of Adcock Ingram

 
• By Anju Ghangurde

Natco Pharma plans to acquire over 35% in Adcock Ingram as it seeks to open up new opportunities in South Africa for both portfolio and market expansion. The Hyderabad, India-based company expects to

Scrip

Mounjaro In India: Price Differential, Window Of Opportunity

 
• By Anju Ghangurde

Eli Lilly’s blockbuster obesity and type 2 diabetes therapy, Mounjaro (tirzepatide) has made its India debut throwing down the gauntlet to rival Novo Nordisk, currently in the wings with Wegovy (injec

Generics Bulletin

Breckenridge To Strengthen Generic Everolimus Launch With Copay Program

Breckenridge Pharmaceutical and its Indian partner Natco Pharma have celebrated US Food and Drug Administration approval for their generic everolimus tablets for oral suspension, referencing Novartis’